NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 327 filers reported holding NOVOCURE LTD in Q1 2021. The put-call ratio across all filers is 0.32 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $86,000 | +17.8% | 1,239 | +41.0% | 0.00% | – |
| Q1 2022 | $73,000 | +28.1% | 879 | +16.7% | 0.00% | – |
| Q4 2021 | $57,000 | -36.0% | 753 | -1.3% | 0.00% | -100.0% |
| Q3 2021 | $89,000 | -66.7% | 763 | -36.7% | 0.00% | -50.0% |
| Q2 2021 | $267,000 | +468.1% | 1,205 | +240.4% | 0.00% | +100.0% |
| Q1 2021 | $47,000 | +213.3% | 354 | +316.5% | 0.00% | – |
| Q4 2020 | $15,000 | +50.0% | 85 | 0.0% | 0.00% | – |
| Q3 2020 | $10,000 | -28.6% | 85 | -62.7% | 0.00% | – |
| Q2 2020 | $14,000 | -64.1% | 228 | -55.8% | 0.00% | -100.0% |
| Q3 2019 | $39,000 | +69.6% | 516 | +41.0% | 0.00% | 0.0% |
| Q2 2019 | $23,000 | – | 366 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 350,884 | $24,386,000 | 14.72% |
| HARTLINE INVESTMENT CORP/ | 335,191 | $58,001,000 | 8.32% |
| Deep Track Capital, LP | 1,341,300 | $93,220,000 | 6.13% |
| MORGAN JESS S & CO INC | 48,345 | $3,360,000 | 3.48% |
| Taylor Frigon Capital Management LLC | 68,908 | $4,789,000 | 2.49% |
| HighVista Strategies LLC | 28,007 | $1,946,000 | 1.18% |
| Private Harbour Investment Management & Counsel, LLC | 13,106 | $911,000 | 1.01% |
| Lloyd Park, LLC | 9,325 | $648,000 | 0.68% |
| Baillie Gifford | 9,116,230 | $633,578,000 | 0.65% |
| HAP Trading, LLC | 110,900 | $10,575,000 | 0.53% |